Vekacia (ciclosporin)
Orphan
- Region
- 🇪🇺 EU
- Active substance
- ciclosporin
- Company
- Novagali Pharma S.A.
- Status
- Application withdrawn
- Therapeutic area
- Conjunctivitis, Allergic
- Designations
- Orphan
- Application
- EMEA/H/C/000904
- Official record
- www.ema.europa.eu
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Ikervis Authorised · Santen Oy
- 🇪🇺 Verkazia Authorised · Santen Oy
- 🇪🇺 Vevizye Authorised · Laboratoires Théa
- 🇪🇺 Restaysis Application withdrawn · Allergan Pharmaceuticals International Limited
Follow Vekacia
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.